Adenosine: an endogenous regulator of innate immunity.

By G. Haskó, B. Cronstein. Trends in immunology, 2004

933 citations recorded by the source corpus.

Subfields: Epidemiology, Obstetrics and Gynecology, Physiology

View Paper: https://www.semanticscholar.org/paper/5917fa3574a3035876f254d202c731c84fab95c7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. P. Pacher
2. O. Levy
3. Luca Antonioli
4. E. Vizi
5. G. Haskó
6. M. Perretti
7. T. Lawrence

In Obstetrics and Gynecology

1. P. Pacher
2. O. Levy
3. Luca Antonioli
4. E. Vizi
5. G. Haskó

In Physiology

1. P. Pacher
2. Luca Antonioli
3. O. Levy
4. E. Vizi
5. G. Haskó
6. C. Serhan

Citations in the corpus

• Inflammatory Resolution: new opportunities for drug discovery (2004, background): “These include methotrexate, sulphasalazine and FK506, which are thought to exert their effects by increasing adenosine releas”
• CD39 and CD73 in immunity and inflammation (2013, positive): “in adenosine concentration, consequent to the rapid degradation of ATP by ecto-enzymes, can lead to a substantial inhibitory effect, thus establishing a feedback loop to avoid potential tissue injury arising from a prolonged inflammatory response [54,55].”
• Innate immunity of the newborn: basic mechanisms and clinical correlates (2007, background): “Adenosine, an endogenous purine metabolite for which concentrations rise during hypoxia, has immunomodulatory propertie”